Medication info
Olgotan Tablet 10 mg (Olmesartan Medoxomil)

Olgotan Tablet 10 mg (Olmesartan Medoxomil)

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›10mg / 1 tablet
Manufacturer / importer
Il Yang Pharmaceuticals Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201101841 · Approved 2011.03.31 · Insurance code 641704170

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily and may be taken with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). For patients who may have intravascular volume depletion (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dosage adjustment is necessary when this medicine is administered to patients aged 65 years and older. No overall differences in efficacy and safety have been observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily and may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
Child dose
<Pediatric patients> The safety and efficacy in children have not been established.

Ingredients

Manufacturer
Il Yang Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension refers to a condition where blood pressure is persistently high without any specific cause. This medication effectively lowers blood pressure, reducing the risk of cardiovascular diseases and helping to prevent damage to blood vessels and organs. Regular use can help maintain blood pressure control and a healthy lifestyle. It is used to treat essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily and may be taken with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). For patients who may have intravascular volume depletion (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dosage adjustment is necessary when this medicine is administered to patients aged 65 years and older. No overall differences in efficacy and safety have been observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily and may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.

Child dose

<Pediatric patients> The safety and efficacy in children have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially during the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to this medication or are pregnant or breastfeeding, those undergoing kidney dialysis, or those with severe liver impairment or bile duct obstruction or lactose intolerance should not take this medication. Patients with decreased blood volume or low sodium levels, reduced kidney function, kidney vascular issues, or at risk of hyperkalemia should take this medication with caution and have their blood pressure and kidney function monitored frequently. Dizziness may occur while taking this medication, so caution should be exercised when driving or operating hazardous machinery. This medication is generally safe to use, but side effects such as dizziness, headache, abdominal pain, muscle pain, and rash may occur rarely. If severe side effects appear, consult a doctor immediately. This medication may interact when taken with other antihypertensive drugs, potassium-sparing diuretics, lithium, and non-steroidal anti-inflammatory drugs, so you must inform your doctor or pharmacist of all medications you are currently taking. Taking this medication during pregnancy can lead to serious issues such as impaired kidney function in the fetus, oligohydramnios, and malformations, so it should be avoided if planning to become pregnant or if pregnant. Consultation with a doctor is necessary when needed. While breastfeeding, this medication can be transmitted partially through breast milk and may affect the infant, so you should discuss with a doctor whether to continue breastfeeding or to discontinue medication. Safety in children has not been established, so it should be used cautiously in children. In the elderly, the concentration of this medication in the body may increase, necessitating caution during administration. In cases of overdose, symptoms like hypotension and palpitations may occur, and immediate medical treatment should be sought.

Side effects

  • Dizziness
  • back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • flu-like symptoms
Show 39 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastroenteritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • asthenia
  • angioedema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute kidney failure
  • elevated blood creatinine
  • hair loss
  • pruritus
  • urticaria
  • headache
  • palpitations
  • hypertension
  • epistaxis
  • upper respiratory infection
  • asthma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture, at room temperature between 1 and 25 degrees Celsius. Maintaining proper temperature and container will help preserve the medication's efficacy and safety.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.